This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

UK life sciences funding trend holds promise for IP valuation

By Douglas Clarke-Williams ( July 29, 2025, 15:49 GMT | Insight) -- Start-ups and scale-ups developing intellectual property in the life sciences sector should take heart from funding data for the first half of 2025, an industry association has said. As the UK government works to realize plans to help IP-rich entities get better access to funds, the industry is keen to ensure that early-stage companies don’t miss out.Start-ups and scale-ups developing intellectual property in the life sciences sector should take heart from funding data for the first half of 2025, an industry association has said....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections